Literature DB >> 20176130

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

D Allan Butterfield1, Miranda L Bader Lange, Rukhsana Sultana.   

Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder. A number of hypotheses have been proposed to explain AD pathogenesis. One such hypothesis proposed to explain AD pathogenesis is the oxidative stress hypothesis. Increased levels of oxidative stress markers including the markers of lipid peroxidation such as acrolein, 4-hydroxy-2-trans-nonenal (HNE), malondialdehyde, etc. are found in brains of AD subjects. In this review, we focus principally on research conducted in the area of HNE in the central nervous system (CNS) of AD and mild cognitive impairment (MCI), and further, we discuss likely consequences of lipid peroxidation with respect to AD pathogenesis and progression. Based on the research conducted so far in the area of lipid peroxidation, it is suggested that lipid accessible antioxidant molecules could be a promising therapeutic approach to treat or slow progression of MCI and AD. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176130      PMCID: PMC2886168          DOI: 10.1016/j.bbalip.2010.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  79 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

Review 2.  Aminophospholipid asymmetry: A matter of life and death.

Authors:  Krishnakumar Balasubramanian; Alan J Schroit
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

4.  Regional membrane phospholipid alterations in Alzheimer's disease.

Authors:  M R Prasad; M A Lovell; M Yatin; H Dhillon; W R Markesbery
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins.

Authors:  R Subramaniam; F Roediger; B Jordan; M P Mattson; J N Keller; G Waeg; D A Butterfield
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

6.  Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

7.  Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Authors:  Debra Boyd-Kimball; Hafiz Mohmmad Abdul; Tanea Reed; Rukhsana Sultana; D Allan Butterfield
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

8.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

9.  Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.

Authors:  Sung-Chun Tang; Justin D Lathia; Pradeep K Selvaraj; Dong-Gyu Jo; Mohamed R Mughal; Aiwu Cheng; Dominic A Siler; William R Markesbery; Thiruma V Arumugam; Mark P Mattson
Journal:  Exp Neurol       Date:  2008-05-29       Impact factor: 5.330

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

View more
  100 in total

Review 1.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

Review 2.  Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Jacqueline R Kulbe; Edward D Hall
Journal:  Exp Neurol       Date:  2020-04-20       Impact factor: 5.330

3.  Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

Authors:  Giovanna Cenini; Amy L S Dowling; Tina L Beckett; Eugenio Barone; Cesare Mancuso; Michael Paul Murphy; Harry Levine; Ira T Lott; Frederick A Schmitt; D Allan Butterfield; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

4.  Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Andrew Ferree; Katelyn Smith; Eugenio Barone; Marzia Perluigi; Raffaella Coccia; William Pierce; Jian Cai; Cesare Mancuso; Rachel Squillace; Manfred Wiengele; Isabella Dalle-Donne; Benjamin Wolozin; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-03-20       Impact factor: 8.401

Review 5.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

Authors:  Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2013-10-09

Review 6.  Exploring Biomarkers for Alzheimer's Disease.

Authors:  Neeti Sharma; Anshika Nikita Singh
Journal:  J Clin Diagn Res       Date:  2016-07-01

7.  Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

Authors:  Tourandokht Baluchnejadmojarad; Seyed-Mahdi Mohamadi-Zarch; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2019-08-17       Impact factor: 3.584

8.  Can urinary excretion rate of 8-isoprostrane and malonaldehyde predict postoperative cognitive dysfunction in aging?

Authors:  Qinghao Cheng; Jiawan Wang; Anshi Wu; Rujin Zhang; Lei Li; Yun Yue
Journal:  Neurol Sci       Date:  2013-02-05       Impact factor: 3.307

9.  4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart.

Authors:  Qingling Li; Sushabhan Sadhukhan; Jessica M Berthiaume; Rafael A Ibarra; Hui Tang; Shuang Deng; Eric Hamilton; Laura E Nagy; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

10.  Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-12-12       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.